Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pyridoxine-dependent pathway is a metabolic route where the function or synthesis of biomolecules depends on pyridoxine (vitamin B6) or its active forms, especially pyridoxal 5'-phosphate (PLP). It is primarily associated with lysine metabolism, neurotransmitter synthesis, and the etiology of pyridoxine-dependent epilepsy (PDE) due to mutations in the ALDH7A1 gene, which encodes antiquitin. Antiquitin deficiency leads to the accumulation of toxic intermediates that interfere with PLP function, impairing neurotransmitter synthesis. Treatment involves pyridoxine supplementation to restore PLP function.
Cofactor supplementation (pyridoxine/PLP)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyridoxine-dependent pathway.